Anatara's CEO, Steve Lydeamore will be presenting to investors during the Bioshares Biotech Summit this Friday, and at a Monsoon Communications Twilight Investor Briefing event in Melbourne during August. Any investors interested in attending these presentations are invited to reach out.
Details and registration links are summarised below:
Bioshares Biotech Summit
Steve will speak in a session on Gut and the Microbiome alongside Microba and Atmo Biosciences:
* Friday, 26th July 2019
* 5:00pm to 6:00pm
* Skyline, Queenstown, New Zealand
To see the Bioshares program and event information, visit:
http://www.bioshares.com.au/program2019.htm
Monsoon Communications Twilight Investor Briefing
Steve will provide an update on Anatara's work in gastrointestinal health for both humans and animals, alongside AdAlta Ltd:
* Thursday 22nd August 2019
* 4.15pm for 4.30pm
* FB Rice Boardroom, Level 14, 90 Collins Street, Melbourne
To register, contact info@monsoon.com.au
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
Contact
Investor and Media inquiriesSteven Lydeamore
Chief Executive Officer
Anatara Lifesciences Ltd
T: +61-438-027-172
E: slydeamore@anatara.com
Sue MacLeman
Chair
Anatara Lifesciences Ltd
T: +61-437-211-200
E: smacleman@anatara.com
Related Companies
Related Industry Topics: